companydata.dkSMARTPRACTICE DENMARK ApS
CVR: 89669510
Secondary names: MEKOS ApS, MEKOS LABORATORIES ApS
The financial health of SMARTPRACTICE DENMARK ApS appears robust, with a consistent upward trajectory in both revenue and profit over the past few years. Revenue increased from 49.2 million DKK in 2020 to 76.9 million DKK in 2024, while profit rose from 2.6 million DKK to 19.7 million DKK in the same period, indicating strong operational growth and improving margins. Equity has remained relatively stable, though it slightly decreased from 48.8 million DKK in 2023 to 48.5 million DKK in 2024, suggesting a potential concern regarding capital retention. Overall, the company is well-positioned within the pharmaceutical manufacturing industry, demonstrating solid performance and profitability.
AI-generated summary
Overview
Details
Contact
Purpose
Selskabets formål er udvikling, produktion og salg af et testsystem til diagnosticering af kontaktallergi, samt al virksomhed som efter bestyrelsens skøn er beslægtet hermed.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 76.9 mio. | 19.7 mio. | 107.5 mio. | 48.5 mio. | 48 | |
History
Ownership
Management
Directors
Board
Production units (1)
Similar companies
Companies in the same industry and area